Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

Gala vs Midi Health

Gala and Midi Health sell different medications; this is what separates them.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
Gala logo

Gala

8.7
★★★★☆4.4/5

Best for: moving between compounded and brand without changing seller

Visit Gala →
VS
Midi Health logo

Midi Health

4.6
★★☆☆☆2.3/5

Best for: coverage in all 50 states, which most sellers will not confirm

Visit Midi Health →

If you are choosing between Gala and Midi Health, price alone will not settle it. Gala leads our six-part score, 8.7 to 4.6.

Gala vs Midi Health price

Gala publishes $149 a month. Midi Health does not post a GLP-1 price we can quote, so you would only learn its cost after an intake.

Medications and formats

Gala lists semaglutide and tirzepatide; Midi Health does not name its drug.

On format, Gala prices compounded injections and brand-name pens, while Midi Health posts no priced format.

If you want the FDA-approved brand rather than a compounded version, Gala is the only one of the two with a brand-name price.

Where each one treats patients

Gala lists 50 states, and Midi Health lists 50 states.

They overlap in 50 states.

Pricing

Gala

Compounded GLP-1 (all doses)Compounded
$179$129/mo
Save 28% right now
semaglutide

$179/mo on a yearly subscription, all doses included. Gala's FAQ says 'starting at just $199 per month (with a 3-month plan).' A promo page offers 'starting at $129/month with $120 off your first shipment' on monthly, 3-, 6- and 12-month plans. Exact plan prices appear only after the intake questionnaire.

Compounded GLP-1/GIP (all doses)Compounded
$179/mo
tirzepatide

$179/month on a yearly subscription, all doses included; the $120-off-first-shipment promo applies. Tirzepatide plan prices are shown only after intake.

Microdosing GLP-1/GIPCompounded
$149/mo
tirzepatide

$149/month, yearly subscription; 'Low-dose GLP-1/GIP for sustained energy, sleep and metabolic balance.'

Ozempic (brand)Brand-name
$1299/mo
semaglutide

'Ozempic® Brand-name semaglutide $1,299/month' — unchanged. Wegovy pill still 'Coming soon / Pricing at launch' (not a priced row).

Midi Health

Self-pay initial visittelehealth visit
$250/mo

Per-visit self-pay fee, NOT a monthly medication price; GLP-1 medication billed separately or through insurance. No compounded medication price is published on the current site.

Self-pay continued care visittelehealth visit
$150/mo

Per-visit self-pay fee; medication not included. Under insurance you instead pay your standard copay + deductible.

What each price covers

Gala's price also covers the clinician visit, the medication itself and shipping, which Midi Health does not claim.

Gala is silent on lab work and coaching.

Midi Health does not say what its price includes.

That matters most for the drug: unless Midi Health confirms otherwise, budget for medication on top of its listed price.

Gala

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

Midi Health

Inclusions not disclosed.

Where each one scores higher

Overall, Gala scores 8.7 and Midi Health 4.6 out of 10.

Gala is stronger on value (8.7 vs 3.0), effectiveness (10.0 vs 5.0), user experience (8.0 vs 2.5), trust & safety (7.5 vs 5.0) and support (7.0 vs 5.0).

Accessibility is within half a point.

How we score

Gala

8.7/10

Overall

Midi Health

4.6/10

Value25%

8.7A
vs
B
3.0

Effectiveness25%

10.0A
vs
B
5.0

User Experience15%

8.0A
vs
B
2.5

Trust & Safety15%

7.5A
vs
B
5.0

Accessibility10%

10.0A
vs
B
10.0

Support10%

7.0A
vs
B
5.0

FDA warning letters

Neither Gala nor Midi Health has an FDA warning letter on record with us.

Features & Coverage

FeatureGalaMidi Health
Starting Price$149/moNot published
Features✓7 features5 features
States Available5050
Compounded✓ Yes—
Brand Name✓ Yes—
FSA/HSA Accepted——
FDA Warning LettersNoneNone

About Gala

A yearly subscription is the format: compounded semaglutide and compounded tirzepatide are sold that way, with a cheaper microdosing program beside them and brand-name Ozempic on the same menu. The corporate name is AI Coaching Inc., which does business as Gala GLP-1 and is incorporated in Delaware. Providers licensed in every one of the 50 states, plus shipping at no cost, are what the marketing site claims. A Wegovy pill taken orally is flagged as coming soon.

Read our full Gala review →

About Midi Health

Medicare, Medicaid, and Medi-Cal are all refused at Midi Health, though commercial insurance is taken. The platform covers menopause and perimenopause nationwide, in 50 states. GLP-1s are not sold here as a standalone weight-loss product; a clinician may add one at their discretion, a metabolic-health adjunct inside the menopause care framework.

Read our full Midi Health review →

Pros & Cons

Gala

What we like

  • Semaglutide costs $179 a month, close to the $184 median for compounded semaglutide across the sellers we compare
  • Tirzepatide costs $149 a month, 40% below the $250 median for compounded tirzepatide across the sellers we compare
  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price stays the same as your dose goes up
  • The monthly price includes the medication, clinician visits and shipping
  • Serves all 50 states
  • We found no FDA warning letters issued to Gala

Watch-outs

  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Midi Health

What we like

  • Serves all 50 states
  • We found no FDA warning letters issued to Midi Health
  • A live video visit with a clinician is required before a prescription, which is slower than a form and is the more careful intake

Watch-outs

  • You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
  • Ask which pharmacy fills the prescription before you pay, so you can check its license

Our Verdict

Winner: Gala

Gala wins this one, 8.7 to 4.6, above all for moving between compounded and brand without changing seller. Midi Health fits better if coverage in all 50 states, which most sellers will not confirm is your priority.

Choose Gala if…

You want moving between compounded and brand without changing seller and an opening price near $149 a month.

Choose Midi Health if…

You want coverage in all 50 states, which most sellers will not confirm.

Ready to start? GLP-1 providers we have vetted

Telehealth providers, vetted by us, prescribing GLP-1 online.

Vetted by our editors · no insurance required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

7.3

RNK Health

An oral route if you will not self-inject

9.2

He & She MD

Starting below a standard dose, with microdose tiers

5.9

Wellorithm

Compounded semaglutide at $247/month

Gala vs Midi Health: FAQ

Only Gala publishes a price ($149 a month). Midi Health quotes after sign-up.
No. Gala lists semaglutide and tirzepatide; Midi Health lists no named drug.
Both list 50 states and share 50.
Only Gala includes the clinician visit, the medication itself and shipping.
Gala has none. Midi Health has none.
Gala pays us a commission on sign-ups through our links; Midi Health does not. Scores are computed the same way for both.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.